NCT01571570View on ClinicalTrials.gov

A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435.

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

TMC435 150 mg capsule

single oral dose of 150 mg TMC435 150 mg capsule

DRUG

TMC435 150 mg oral suspension (20 mg/mL)

single oral dose of 150 mg TMC435 oral suspension

DRUG

TMC435 150 mg oral solution (10 mg/mL)

single oral dose of 150 mg TMC435 oral solution

DRUG

TMC435 150 mg capsule concept K

single oral dose of 150 mg TMC435 capsule concept K

DRUG

TMC435 150 mg capsule concept L

single oral dose of 150 mg TMC435 capsule concept L

Trial Locations (1)

Unknown

Harrow

All Listed Sponsors
lead

Janssen R&D Ireland

INDUSTRY

NCT01571570 - A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435. | Biotech Hunter | Biotech Hunter